Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 9/20 | 0.49 |
| ▸ | NOTUM | Q6P988 | 5/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | UBE2N | P61088 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7923011 | 0.81 | SIGMAR1 (0.49) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL7923053 | 0.81 | SIGMAR1 (0.49) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL7757989 | 0.81 | CYP2C9 (0.43) | NOTUMALDH1A1LMNAMAPTL3MBTL1 | |
| SCHEMBL28966719 | 0.81 | SIGMAR1 (0.56) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17764753 | 0.77 | APOBEC3G (0.36) | SIGMAR1ALDH1A1L3MBTL1KDM4E | |
| SCHEMBL28276549 | 0.77 | SIGMAR1 (0.46) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL17764744 | 0.77 | SIGMAR1 (0.43) | SIGMAR1 | |
| SCHEMBL29554825 | 0.76 | ALDH1A1 (0.47) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL31432743 | 0.75 | SIGMAR1 (0.60) | SIGMAR1ALDH1A1CYP1A2CYP3A4 | |
| SCHEMBL28826934 | 0.75 | ALDH1A1 (0.46) | SIGMAR1NOTUMALDH1A1CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6221808-B1 | Method for controlling parasitic fungi in cultivated plants | BASF AKTIENGESELLSCHAFT (DE) | 2001-04-24 | — | — | US | claimed |
| US-20160145219-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2016-05-26 | — | — | US | disclosed |
| CN-103609575-B | A kind of bactericidal composition containing tetramycin and pyraclostrobin | HAILIR PESTICIDES AND CHEMICALS GROUP CO.,LTD. (CN) | 2016-01-20 | — | — | CN | disclosed |
| CN-103609575-A | Bactericidal composition containing tetramycin and pyraclostrobin | HAILIR PESTICIDES & CHEM GROUP | 2014-03-05 | — | — | CN | disclosed |
| CN-103355333-A | Sterilization composition containing pyraclostrobin and boscalid | HAILIR PESTICIDES & CHEM GROUP | 2013-10-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145219-A1 | STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI | DPM1, CROCC, SNX1 | SIGMAR1 3846/4885NOTUM 2527/4885ALDH1A1 3309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.